Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros

Métodos Terapéuticos y Terapias MTCI
Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Opt Express ; 16(14): 10721-7, 2008 Jul 07.
Artículo en Inglés | MEDLINE | ID: mdl-18607488

RESUMEN

This paper demonstrates a direct comparison of optical frequency combs (OFCs) with different repetition rates without a stable intermediate laser using a single-mode comb-injection-lock technique. Two OFCs based on Ti:Sapphire mode-locked lasers were compared utilizing a single-mode diode laser for the selection and the amplification of one mode of an OFC by comb-injection, which makes the direct comb comparison possible. The frequencies of the two combs were found to agree within 0.019 Hz at 352 THz with the uncertainty of 0.25 Hz (7.1 x 10(-16) ). This is one of the best results among the comparisons of combs referenced to a microwave frequency. This technique simplifies the comb comparison utilities and can be applied even when repetition rates differ.


Asunto(s)
Rayos Láser , Óptica y Fotónica , Óxido de Aluminio/química , Diseño de Equipo , Microondas , Reproducibilidad de los Resultados , Titanio/química
2.
Gene ; 177(1-2): 93-7, 1996 Oct 24.
Artículo en Inglés | MEDLINE | ID: mdl-8921851

RESUMEN

SH-PTP2 is a protein tyrosine phosphatase which contains two src homology 2 (SH2) domains. A partial cDNA clone encoding chicken SH-PTP2 was generated by RT-PCR and used as a probe to screen several chicken cDNA libraries. Two overlapping cDNA clones were identified and the nucleotide sequence of chicken SH-PTP2 containing the entire protein-coding region was determined. The deduced amino acid sequence shares 98% and 94% identity, respectively with the corresponding human and Xenopus proteins. Northern and Western blot analyses show that chicken SH-PTP2 is expressed ubiquitously like those of mammals and Xenopus. This suggests that chicken SH-PTP2 may have analogous biological roles to those of mammals.


Asunto(s)
Proteínas Tirosina Fosfatasas/genética , Secuencia de Aminoácidos , Animales , Secuencia de Bases , Pollos , Clonación Molecular , ADN Complementario , Expresión Génica , Humanos , Péptidos y Proteínas de Señalización Intracelular , Datos de Secuencia Molecular , Proteína Tirosina Fosfatasa no Receptora Tipo 11 , Proteína Tirosina Fosfatasa no Receptora Tipo 6 , ARN Mensajero/metabolismo , Homología de Secuencia de Aminoácido
3.
Cancer Chemother Pharmacol ; 33 Suppl: S128-33, 1994.
Artículo en Inglés | MEDLINE | ID: mdl-8137473

RESUMEN

The aim of the present study was to deliver a high internal radiation dose to small hepatocellular carcinoma (HCC) lesions in an attempt to treat this disease. A total of 18 patients with HCC lesions measuring less than 4.5 cm in diameter (25 lesions) were treated with superselective intra-arterial injection of I-131-labeled Lipiodol (370-1,100 MBq in 3-5 ml) using a 5-F or coaxial catheter. All the lesions were nodular, multinodular, or hypervascular on pretreatment angiography. In all, 15 lesions that received over 180 Gy of cumulative radiation decreased in size in proportion to the Lipiodol retention on CT, and no pericapsular recurrence was found on angiography after 14-54 months of follow-up. In five patients who subsequently underwent surgery, 65% to 100% tumor necrosis was detected. No abnormal change in liver function tests or untoward clinical symptom of the lung, thyroid, or bone marrow was detected in patients who survived for more than 3 years after the treatment. Superselective high-dose internal radiation therapy of small HCC offers hope of treatment and long-term local control without complications.


Asunto(s)
Carcinoma Hepatocelular/radioterapia , Radioisótopos de Yodo/uso terapéutico , Neoplasias Hepáticas/radioterapia , Adulto , Anciano , Femenino , Estudios de Seguimiento , Humanos , Inyecciones Intraarteriales , Radioisótopos de Yodo/administración & dosificación , Aceite Yodado/administración & dosificación , Masculino , Persona de Mediana Edad , Dosificación Radioterapéutica
4.
Cancer ; 68(9): 1878-84, 1991 Nov 01.
Artículo en Inglés | MEDLINE | ID: mdl-1717129

RESUMEN

Internal radiation therapy with subsegmental arterial injection of iodine 131(131I)-labeled iodized oil (Lipiodol; Laboratorie, Guerbet, France) was evaluated in 24 patients with nodular hepatocellular carcinoma (HCC) ranging from 2.5 to 8.0 cm in size. 131I Lipiodol (555 to 2220 MBq in 3 to 8 ml) was injected depending on the tumor size. Tumor reduction was seen in 88.9% of tumors smaller than 4.0 cm in diameter, 65.5% of tumors between 4.1 to 6.0 cm, and 25.0% of tumors larger than 5.1 cm. The tumor size reduction corresponded to the gradual drop of serum alpha-fetoprotein (AFP) levels and devascularization on follow-up angiography. Adverse reactions from treatment included fever, mild abdominal pain, nausea, and elevation of transaminases. These were mild and well tolerated by patients. This method provided long-term local control without complications related to the thyroid, lung, gastrointestinal tract, and bone marrow.


Asunto(s)
Carcinoma Hepatocelular/radioterapia , Radioisótopos de Yodo/uso terapéutico , Aceite Yodado/uso terapéutico , Neoplasias Hepáticas/radioterapia , Adulto , Anciano , Carcinoma Hepatocelular/sangre , Carcinoma Hepatocelular/patología , Estudios de Seguimiento , Arteria Hepática , Humanos , Inyecciones Intraarteriales , Radioisótopos de Yodo/administración & dosificación , Aceite Yodado/administración & dosificación , Neoplasias Hepáticas/sangre , Neoplasias Hepáticas/patología , Persona de Mediana Edad , Dosificación Radioterapéutica , Radioterapia Asistida por Computador , Inducción de Remisión , alfa-Fetoproteínas/análisis
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA